Adam Zerda is Director, Antimicrobial Resistance (AMR) Strategy and Development for BD. BD efforts to help combat AMR include a broad portfolio of solutions strategically positioned to play an active role in addressing this threat. In his role, Adam is responsible for developing and executing BD’s strategy for combatting the challenge of AMR globally by working to help build awareness of AMR, engage external stakeholders in policy and advocacy efforts around AMR, and develop training and process improvement programs, focusing specifically on infection prevention and antimicrobial stewardship. In leading BD’s AMR efforts, Adam is accountable for developing and implementing organization-wide, cross-functional alignment around this issue by working collaboratively with businesses, regions and functions. Prior to this role, Adam has held positions in business development, strategic innovation and research and development at BD. He joined the company in 2007. Prior to BD, Adam held roles in product development for GE Plastics. Adam has a Ph.D. in Polymer Science and Engineering (2002) from the University of Massachusetts in Amherst and a B.S. in Chemistry (1998) from TCU. He is based in North Carolina where he additionally sits on the board of North Carolina BIO.